Startup profile · funding coverage
Centerline Biomedical funding, valuation and investors
Cleveland Clinic spinout of IOPS — non-X-ray 3D endovascular surgical navigation.
Keep track of Centerline Biomedical
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Not publicly disclosed
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
Not publicly disclosed
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
growth · Cleveland, OH
Overview
Centerline Biomedical is a Cleveland Clinic spinoff commercializing IOPS, a 3D GPS-like surgical navigation technology for endovascular procedures that aims to reduce reliance on X-ray fluoroscopy. Ohio Life Sciences directory lists 10000 Cedar Ave, Cleveland, OH; additional Renaissance Parkway addresses appear in directories.
Why Centerline Biomedical is interesting
Clinic commercialization path: Intra-Operative Positioning System (IOPS) to improve endovascular outcomes and cut radiation exposure.
Product & use cases
Intra-operative 3D navigation for endovascular surgery without continuous X-ray dependence.
- Endovascular aneurysm repair navigation
- Cath lab radiation reduction initiatives
Key facts
- Cleveland Clinic spinoff
- Product: IOPS endovascular navigation
- Goal: improve outcomes and reduce radiation exposure
- Cleveland, OH HQ / Clinic campus adjacency
Competitive landscape
Edge: Clinic-origin IP focused on radiation-light navigation.
-
Philips / Siemens image guidance incumbent
Imaging OEM guidance suites.
-
Centerline peers in surgical navigation direct
Emerging endovascular nav startups.
Industries
Market / IPO context
Editorial / static context — not a live quote.
FAQs about Centerline Biomedical
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.